Cleared Traditional

K190847 - REDAPT Blade Augments

K190847 is the FDA 510(k) clearance for REDAPT Blade Augments by Smith & Nephew, Inc.. It is a Class 2 Orthopedic device (product code LPH) cleared through the Traditional 510(k) pathway after a 207-day FDA review.

K190847 · Smith & Nephew, Inc. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2019
Decision
207d
Days
Class 2
Risk

K190847 is an FDA 510(k) clearance for the REDAPT Blade Augments. Classified as Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented (product code LPH), Class II - Special Controls.

Submitted by Smith & Nephew, Inc. (Memphis, US). The FDA issued a Cleared decision on October 25, 2019 after a review of 207 days - an extended review cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3358 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Smith & Nephew, Inc. devices

Submission Details

510(k) Number K190847 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 01, 2019
Decision Date October 25, 2019
Days to Decision 207 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
85d slower than avg
Panel avg: 122d · This submission: 207d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LPH Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3358
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - LPH Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented

All 441
Devices cleared under the same product code (LPH) and FDA review panel - the closest regulatory comparables to K190847.
Zimmer Biomet 12/14 CoCr Femoral Head and Freedom Head
K183457 · Zimmer, Inc. · Nov 2019
Delta Multihole TT Pro Acetabular System
K191622 · Lima Corporate S.P.A. · Nov 2019
OR3O Dual Mobility System
K191002 · Smith & Nephew, Inc. · Oct 2019
Trident II Acetabular System
K191358 · Howmedica Osteonics Corp. A.K.A. Stryker Orthopaedics · Oct 2019
iNSitu Total Hip System
K192071 · Theken Companies, LLC · Aug 2019
Conformis BeneFIT Hip System
K190904 · Conformis, Inc. · Aug 2019